Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Immunic Therapeutics and Vital Therapies Complete Transaction Creating ...
Immunic reveals MS drug trial success
Career - Immunic Therapeutics
Immunic CEO on key 2025 highlights and 2026 milestones | NASDAQ:IMUX
Immunic Inc set to bring relief with encouraging results | Proactive
Proactive on LinkedIn: Immunic chief medical officer discusses ...
Immunic CMO discusses role of clinical trials in biotech development ...
Immunic CEO talks BIO-Europe 2025, MS trials, and IMU-856
Immunic secures key patent, boosting MS drug exclusivity and global IP ...
Immunic Inc eyeing “big step” for multiple sclerosis patients - Xbee Daily
Immunic Therapeutics reaches major milestone with completion of ENSURE ...
Immunic Therapeutics on LinkedIn: #imux #ms #multiplesclerosis #rrms #pms
#neurology | Immunic Therapeutics
Immunic, Inc. Q3 2024 Earnings Call Recording – Immunic Therapeutics
World Brain Day: Immunic targets MS with new therapy – Immunic Therapeutics
Immunic Therapeutics on LinkedIn: Immunic, Inc. InvestorRoom - Events ...
Immunic Company and Product Overview
Immunic Therapeutics - Crunchbase Company Profile & Funding
Immunic Therapeutics advances MS Drug , Phase 2 CALLIPER trial readout ...
Immunic Therapeutics on LinkedIn: Immunic Receives Notice of Allowance ...
Immunic Therapeutics on LinkedIn: #immunic #imux #biotech #innovation # ...
Immunic Therapeutics Employee Perks & Benefits | Levels.fyi
Immunic Therapeutics on LinkedIn: #immunic #wedbush #imux #lifescience ...
Immunic Therapeutics on LinkedIn: #immunic #investorrelations #ir # ...
Immunic Therapeutics taking a "unique approach" in biopharma - YouTube
Immunic Presents Positive Clinical and Preclinical data for IMU-856, a ...
Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of ...
Immunic Therapeutics on LinkedIn: #immunic #vidofludimuscalcium #imu838 ...
Immunic highlights MS treatment progression at BIO International ...
Immunic announced first patients enrolled in investigator-sponsored ...
Immunic Therapeutics on LinkedIn: #ms #multiplescerlosis #pms #rms # ...
Immunic Therapeutics on LinkedIn: #immunology #autoimmunedisease # ...
Immunic has a blockbuster clinical pipeline to treat multiple sclerosis ...
Immunic Therapeutics: Interview With CEO Dr. Daniel Vitt About The ...
Immunic Prices $65M Oversubscribed Public Offering for Drug Development ...
Immunic signs agreement to in-license assets to treat viral infections
Pipeline - Immunic Therapeutics
Immunic Therapeutics on LinkedIn: #immunic #imux #vidofludimus #imu838 ...
Immunic completes enrollment for Phase 2 MS trial - BioTuesdays
Immunic Therapeutics | LinkedIn
Immunic Reports Positive Data from Multiple Sclerosis Trial - PRISM ...
Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current ...
Immunic Therapeutics on LinkedIn: #wbd2024 #worldbrainday # ...
#isscd #lasscd #imu856 #celiac #celiacdisease #imux #immunic | Immunic ...
#immunic | Immunic Therapeutics
#actrims2025 #neuroprotection #vidofludimus #imux | Immunic Therapeutics
Immunic Therapeutics on LinkedIn: #neurology #multiplesclerosis #ms # ...
Immunic’s IMU-856 shows promise for obesity treatment – Immunic ...
Immunic Therapeutics on LinkedIn: #imux #immunology #immunesystem # ...
Immunic to Participate in Scientific and Industry Conferences in October
Immunic Therapeutics on LinkedIn: #eurohealthleaders #biotechleadership ...
#jpm25 #jpm2025 #imux #vidofludimus #imu838 #imu856 | Immunic Therapeutics
Immunic Therapeutics Announces First Patient Enrolled in Phase 2 ...
Immunic Therapeutics on LinkedIn: #biotechnology #financialreporting # ...
Immunic Therapeutics on LinkedIn: #immunic #holiday #happyeaster # ...
Immunic Therapeutics on LinkedIn: #ksneuroimmune23 #keystone #immunic # ...
Immunic Therapeutics on LinkedIn: #multiplesclerosis #ms #pms #rms # ...
#immunic #financing #investors #imux | Immunic Therapeutics
Immunic Therapeutics auf LinkedIn: #vidofludimus #proactive #imux # ...
Immunic Therapeutics and Aphios Interviews - US Life Sciences 2025
Immunic Therapeutics on LinkedIn: #ibs #ibs #ibsawarenessmonth # ...
Is everything different? | Immunic Therapeutics
Immunic's CALLIPER data: a step forward for PMS treatment | Immunic ...
Immunic Therapeutics on LinkedIn: #sarscov2 #covid19 #multiplescerosis ...
ImmuniC Glow Serum - DrGils
Immunic Therapeutics on LinkedIn: #imove4celiac #celiac #celiacdisease ...
About - Immunic Therapeutics
Immunic Announces Private Placement
Immunic Therapeutics on LinkedIn: #jefferies #immunic #imux # ...
Home - Immunic Therapeutics
Immunic 2025 | Leerink Partners Global Healthcare Conference
Immunic Therapeutics on LinkedIn: #ms #31daysofms #msawareness # ...
#imux | Immunic Therapeutics
Immunic Therapeutics on LinkedIn: #sanfrancisco #jpm23 #jpm2023 # ...
Immunic Inc. - AnnualReports.com
Company Values - Immunic Therapeutics
Immunic Therapeutics on LinkedIn: #bionews #immunic #imux #vidofludimus ...
Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive ...
Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus ...
Immunic to Showcase Innovative Therapies at Upcoming Conferences This ...
Immunic to Showcase Innovations at Upcoming Investor and Scientific ...
Publications - Immunic Therapeutics
Immunic Appoints Patrick Walsh as Chief Business Officer | citybiz
Immunic Therapeutics on LinkedIn: #ensure #vidofludimus #imu838 # ...
Outsourcing in Clinical Trials DACH 2022 - Immunic Therapeutics
Allergies & Immunity - Supplement Guides on Examine in 2025 | Immune ...
Short Interest in Immunic, Inc. (NASDAQ:IMUX) Rises By 14.5%
Other roles | Work in biotech
Immunic, Inc. Successfully Completes $65 Million Public Offering to ...
#immunic #imux #neurology #multiplesclerosis #ms #vidofludimus #imu838 ...
Celebrating the connection between brain and immunity on International ...
#welovethebeautyofscience #vaccineswork #humanlypossible #imux ...
IL-17靶向口服药：IMU-935不敌安慰剂，Immunic股价大跌74%_财富号_东方财富网
Multiple Sclerosis Drug Shows 24% Disease Progression Reduction in ...
Immunic’s long-term treatment hope for multiple sclerosis – ICYMI ...
#biotechbreakthrough #awardwinner #immunic #imux #imu856 #celiacdisease ...
Immunic-Aktie im Fokus: Biotech-Geheimtipp mit Wachstumschance?
Immunic, Inc. Announces First Patients Enrolled in Investigator ...
Pipeline - Immunomic Therapeutics
Immunic, Inc. Successfully Raises $65 Million in Oversubscribed Public ...
GCT - CRO Services, Clinical Research in US, Europe, Asia
Immunic, Inc. Reports Third Quarter 2022 Financial Results and Provides ...
Rx Communications
Transactions Archive | Leerink Partners
Immunic, Inc. Reveals Promising Second Quarter Results and Drug ...
Recent Successes – Farmacon Global
2023 Winners - BioTech Breakthrough Awards
